Dador, Mercedita F.

HRN: 22-86-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/26/2024
05/03/2024
IVT
4.5g
Q8
Cellulitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: